Middleton & Co’s Amgen AMGN Stock Holding History

Middleton & Co’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$319K	Hold	906	–	–	0.04%	137
2025 Q4	$297K	Sell	906 -170	-16%	-$53.9K	0.03%	141
2025 Q3	$304K	Hold	1,076	–	–	0.03%	138
2025 Q2	$300K	Sell	1,076 -200	-16%	-$56.7K	0.03%	136
2025 Q1	$398K	Sell	1,276 -85	-6%	-$25.1K	0.05%	121
2024 Q4	$355K	Buy	1,361 +85	+7%	+$25.2K	0.04%	130
2024 Q3	$411K	Hold	1,276	–	–	0.05%	122
2024 Q2	$399K	Sell	1,276 -125	-9%	-$36.7K	0.05%	120
2024 Q1	$398K	Hold	1,401	–	–	0.05%	127
2023 Q4	$404K	Sell	1,401 -25	-2%	-$6.81K	0.05%	118
2023 Q3	$383K	Sell	1,426 -170	-11%	-$42.4K	0.05%	116
2023 Q2	$354K	Sell	1,596 -400	-20%	-$92.8K	0.05%	124
2023 Q1	$483K	Hold	1,996	–	–	0.07%	106
2022 Q4	$524K	Buy	1,996 +355	+22%	+$95.2K	0.08%	105
2022 Q3	$370K	Sell	1,641 -250	-13%	-$60.6K	0.06%	114
2022 Q2	$460K	Sell	1,891 -112	-6%	-$27.4K	0.06%	112
2022 Q1	$484K	Buy	2,003 +151	+8%	+$34.7K	0.05%	121
2021 Q4	$417K	Buy	1,852 +150	+9%	+$31.7K	0.04%	130
2021 Q3	$362K	Sell	1,702 -150	-8%	-$34.5K	0.04%	130
2021 Q2	$451K	Buy	1,852 +235	+15%	+$57.8K	0.05%	119
2021 Q1	$402K	Sell	1,617 -15	-0.9%	-$3.58K	0.05%	120
2020 Q4	$375K	Hold	1,632	–	–	0.04%	123
2020 Q3	$415K	Sell	1,632 -148	-8%	-$36.7K	0.06%	110
2020 Q2	$420K	Buy	1,780 +725	+69%	+$165K	0.06%	118
2020 Q1	$214K	Hold	1,055	–	–	0.04%	133
2019 Q4	$254K	Hold	1,055	–	–	0.04%	130
2019 Q3	$204K	Buy	+1,055	New	+$203K	0.03%	140
2019 Q2	–	Sell	-1,055	Closed	-$200K	–	139
2019 Q1	$200K	Hold	1,055	–	–	0.03%	137
2018 Q4	$205K	Sell	1,055 -397	-27%	-$77.5K	0.04%	136
2018 Q3	$301K	Hold	1,452	–	–	0.05%	138
2018 Q2	$268K	Sell	1,452 -458	-24%	-$81K	0.05%	142
2018 Q1	$326K	Buy	1,910 +130	+7%	+$23.9K	0.06%	134
2017 Q4	$310K	Hold	1,780	–	–	0.05%	145
2017 Q3	$332K	Hold	1,780	–	–	0.06%	144
2017 Q2	$307K	Hold	1,780	–	–	0.07%	128
2017 Q1	$292K	Buy	1,780 +40	+2%	+$6.65K	0.06%	138
2016 Q4	$254K	Hold	1,740	–	–	0.06%	143
2016 Q3	$290K	Buy	1,740 +395	+29%	+$66.8K	0.07%	139
2016 Q2	$205K	Hold	1,345	–	–	0.05%	154
2016 Q1	$202K	Hold	1,345	–	–	0.05%	153
2015 Q4	$218K	Buy	+1,345	New	+$211K	0.05%	153
2015 Q3	–	Sell	-1,345	Closed	-$206K	–	145
2015 Q2	$206K	Sell	1,345 -100	-7%	-$16K	0.04%	152
2015 Q1	$231K	Hold	1,445	–	–	0.05%	146
2014 Q4	$230K	Hold	1,445	–	–	0.05%	146
2014 Q3	$203K	Buy	+1,445	New	+$189K	0.05%	156

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Middleton & Co's AMGN Position: Q1 2026 in Review

Middleton & Co held its Amgen (AMGN) position steady in Q1 2026 at 906 shares worth $319K. The position accounts for 0.04% of the portfolio, ranked #137.

Middleton & Co first reported a position in AMGN in Q3 2014 and has held it in 45 quarters since. The position peaked at $524K in Q4 2022. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Middleton & Co held 906 shares of Amgen worth $319K as of Q1 2026.
Middleton & Co left its Amgen share count unchanged in Q1 2026.
Amgen made up 0.04% of Middleton & Co's portfolio in Q1 2026, its #137 holding.
Middleton & Co first reported a position in Amgen in Q3 2014 and has held it in 45 quarters since.
Middleton & Co's Amgen position peaked at $524K in Q4 2022.
3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Middleton & Co's 13F filing for Q1 2026, filed 8 May 2026.